[Interventionism in congenital heart disease in Chiapas. The history after thousand cases performed]

Roberto Mijangos-Vázquez1, Rogelio Hernández-Reyes1

  • 1Departamento de Cardiología Intervencionista Pediátrica, Hospital de Especialidades Pediátricas, Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México.

PubMed

Insights

Cardiac catheterization is increasingly treating congenital heart disease in Chiapas, offering an effective alternative to surgery. This minimally invasive approach shows encouraging results, improving pediatric cardiac care.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Context:

  • Congenital heart disease (CHD) presents a significant mortality challenge in low-income countries.
  • Chiapas has seen advancements in its hemodynamics program, increasing the applicability of cardiac catheterization for CHD.
  • Traditional surgical interventions have limitations in resource-constrained settings.

Purpose:

  • To document the comprehensive experience of interventional cardiology for congenital heart diseases in Chiapas.
  • To analyze the evolution and outcomes of cardiac catheterization procedures for CHD in the region from inception to the present.

Summary:

  • A retrospective review of 1000 cardiac catheterizations (April 2016-June 2023) was conducted.
  • 88.5% of procedures were interventional, with a median patient age of 4 years.
  • This highlights the growing role of catheterization in managing pediatric congenital heart conditions.

Impact:

  • Cardiac catheterization is significantly reducing the need for cardiac surgery in pediatric patients with CHD in Chiapas.
  • The study demonstrates encouraging outcomes and a decentralization of specialized cardiac care within the country.
  • This approach offers a more accessible and effective treatment strategy for congenital heart disease in the region.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...